AIG
LUCD icon

American International Group’s Lucid Diagnostics LUCD Stock Holding History

American International Group’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,505
Closed -$8K – 3195
2022
Q1 		$8K Sell
2,505
-177
-7% -$647 ﹤0.01% 3093
2021
Q4 		$14K Buy
+2,682
New +$21.8K ﹤0.01% 3113

Other funds holding LUCD

LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's LUCD Position: Q2 2022 in Review

American International Group sold out of Lucid Diagnostics (LUCD) in Q2 2022, closing a stake of 2,505 shares — an estimated $8K sold.

American International Group first reported a position in LUCD in Q4 2021 and held it in 2 quarters. The position peaked at $14K in Q4 2021. 31 funds tracked by Wall St. Rank hold LUCD as of Q2 2022.

  • American International Group reported no remaining Lucid Diagnostics position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 2,505 Lucid Diagnostics shares in Q2 2022, an estimated $8K.
  • American International Group first reported a position in Lucid Diagnostics in Q4 2021 and held it in 2 quarters.
  • American International Group's Lucid Diagnostics position peaked at $14K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.